The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?

ASGCT 28th Annual Meeting

Let's connect at ASGCT 2025 to discuss our comprehensive CDMO capabilities for advanced therapies, including the development and manufacturing of viral vectors,
cell therapies, and mRNA. 

May 13–17, 2025 | New Orleans, Louisiana | Booth #1527 

About ASGCT 2025, the 28th Annual Meeting

Now in its 28th year, the American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for gene and cell therapy professionals, providing a place for people in the field to learn from the latest scientific research, stay current on new technologies, and make career-advancing connections with peers.

Originally designed as a venue for academic researchers to share their work, the Annual Meeting has grown to serve a wide community encompassing clinicians, bio-industry developers, regulatory agencies, equipment manufacturers, patient advocates, and more. This year’s event will take place in New Orleans from May 13 – 17, 2025.

Event details 

Date: May 13 – 17, 2025

Format: In-person and virtual

Location: New Orleans Ernest N. Morial Convention Center

Booth Number: #1527

Event Website: https://annualmeeting.asgct.org/

Why Thermo Fisher Scientific?

Advanced therapies like cell and gene therapies have the potential to transform healthcare, but moving from translational studies to commercial manufacturing is challenging. An experienced CDMO can make all the difference.

Visit us at booth #1527 in the exhibit hall or schedule a one-on-one meeting with our technical experts using the ASGCT events app to discuss how our advanced therapy development and manufacturing services can support your program’s success.

We look forward to showcasing our comprehensive capabilities, including:

Attend our live sessions

Tools and technology forum presentation

Title: “Transforming lentiviral production: Enhancing titers, infectivity, and yield for breakthrough gene therapies”

Date: Wednesday, May 14, 2025

Time: 2:15 – 2:30 p.m.  CT

Where: The exhibit hall

Speaker: Pouria Motevalian, Ph.D., Director of BioProcess Sciences, Thermo Fisher Scientific

Oral abstract presentation

Title: “Next-gen rAAV processes: Boosting productivity and quality via process intensification and optimized triple transfection for all common AAV serotypes”

Date: Saturday, May 17, 2025

Time: 8:30 – 8:45 a.m. CT

Where: NOLA Theater C

Speaker: Pouria Motevalian, Ph.D., Director of BioProcess Sciences, Thermo Fisher Scientific

Visit Thermo Fisher Scientific at booth #1527

Let’s discuss our cutting-edge development and manufacturing services for advanced therapies. 

Alternatively, schedule a one-on-one meeting with our team of technical experts by clicking below:

 

Continuing education for the pharma industry 

 

Follow us on social for event updates

We look forward to seeing you soon